about
The Surgical Treatment of MycetomaThe mycetoma knowledge gap: identification of research prioritiesMadurella mycetomatis is highly susceptible to ravuconazoleRapid identification of black grain eumycetoma causative agents using rolling circle amplificationPhylogenetic findings suggest possible new habitat and routes of infection of human eumyctomaHand Mycetoma: The Mycetoma Research Centre Experience and Literature Review.Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan.Mycetoma herbal treatment: the Mycetoma Research Centre, Sudan experience.Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma.The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infectionMycetoma: A global medical and socio-economic dilemmaFructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis.Cyclosporine-A therapy-induced multiple bilateral breast and accessory axillary breast fibroadenomas: a case report.In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafineMapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling.A new model for management of mycetoma in the SudanActive matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.Head and neck mycetoma: the mycetoma research centre experience.Merits and pitfalls of currently used diagnostic tools in mycetoma.Mycetoma medical therapy.In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals.Revision of agents of black-grain eumycetoma in the order Pleosporales.The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.Mycetoma: a thorn in the flesh.A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma--A Retrospective Study.Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients.Madurella mycetomatis-Induced Massive Shoulder Joint Destruction: A Management ChallengeMycetoma Pulmonary Secondaries from a Gluteal Eumycetoma: An Unusual Presentation.Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center ExperienceIntegrated Control and Management of Neglected Tropical Skin DiseasesDetection of (1→3)-β-d-Glucan in Eumycetoma Patients.Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.Medical education in the Sudan: its strengths and weaknesses.Mycetoma: a unique neglected tropical disease.Mycetoma laboratory diagnosis: Review article.Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan.Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan.Neglected endemic mycoses.
P50
Q26747537-B09FB752-46FC-4FBB-A744-53FD18BC5D88Q27010109-D0F73CCF-9A81-4916-81B2-5D5AE7A9D27DQ28539848-1CB8482D-E858-4CF2-8AFE-55272F6D0245Q28542522-73C909A4-FE3E-4AF5-A92C-9D569944FF6BQ28703548-22ACFB70-EA7D-4D3B-99DE-E4E423BB09BAQ30376305-FC6488F5-D0C9-429B-B1F9-DF6F3BF00525Q30414918-066B6D61-4784-4F8E-8FB1-15DB3A0A6A32Q31134221-2EA1E1A6-507F-48CC-8293-46C987D63EBEQ31141340-5C48E5D8-6CAD-46FB-B830-1B9A431C8B78Q31166470-F633F6FB-C4DD-4D0A-BF91-85EB547FE342Q33584578-EA0B6363-3904-4784-9D0D-A1F2A32C95E8Q33950715-3292E5EF-7021-4CD8-BEF6-639AD38D9F01Q34084162-0FD0AECD-2512-4267-BDBB-24DDA1557493Q34160621-800FD717-742E-48B9-A35F-7BBB171393C7Q34351182-7613915D-DCEA-4A77-8A41-3EC8001AB5B5Q34428167-70B3D2DA-6A0E-47AB-8F91-FE6C0695C805Q35133359-869AFA58-75CB-489C-A292-87153A4B309DQ35175809-D997EF1D-63F7-4D81-BD36-5376D452CD1BQ35200842-BC64F7FB-5FD9-4131-BECD-6BCFF6DF93E3Q35351362-2297ECA8-60D3-49CA-B7D9-EAECEB88E607Q35551018-D87075D6-182F-4C98-BB4F-05372C30F14DQ35571175-0DBDC64E-187B-4BAF-9E14-021C9A697CBAQ35576645-D3711D9D-E1DA-4407-80E3-D0B1B9DEB59CQ35619292-E8BE759F-92D5-47C8-87DA-F8A06C4C5E6FQ35691062-F84D2F67-D58E-4B17-922C-557ECBC848C2Q35738430-60E27BF0-D68E-4B16-BE29-6E7AC5D4C203Q35762282-237617AE-6B06-484F-8870-01F79A92572DQ36081684-1CF000D0-050A-48F3-8732-142C289568BBQ36094738-6BADD78A-80F7-446D-A2B6-B26843039214Q36154858-8F98C530-CE4B-47B8-99A8-C3A499DC00B3Q36178522-E19FE1F2-D582-48FD-A2AA-68DE3951F2CEQ36253801-966366EE-EFC8-4A1B-94CC-F0BB288651C6Q37280625-0D591348-C258-45CE-B7D2-EA89F93194F7Q38366273-0E9AEF8C-4157-4313-9826-BDC63A2D766CQ38572956-7314355E-17DF-4719-AB85-F5D478F78C33Q38688724-7882DED1-A7C4-4EAD-A202-0E0413382FECQ38863341-AE4987D9-9841-4719-9503-28581806046BQ39471600-D49FFC2F-5700-427D-AC7F-588D7B3F1E30Q39626705-A3D9C17C-01A7-40AE-9CF9-D2FBBF1AE6D5Q40107614-1D58B8C2-19E4-42FE-9183-E4CA291A2A08
P50
description
onderzoeker uit Soedan
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Ahmed Hassan Fahal
@ast
Ahmed Hassan Fahal
@en
Ahmed Hassan Fahal
@es
Ahmed Hassan Fahal
@nl
Ahmed Hassan Fahal
@sl
type
label
Ahmed Hassan Fahal
@ast
Ahmed Hassan Fahal
@en
Ahmed Hassan Fahal
@es
Ahmed Hassan Fahal
@nl
Ahmed Hassan Fahal
@sl
prefLabel
Ahmed Hassan Fahal
@ast
Ahmed Hassan Fahal
@en
Ahmed Hassan Fahal
@es
Ahmed Hassan Fahal
@nl
Ahmed Hassan Fahal
@sl
P106
P1153
7003586025
P21
P214
32146331908718691841
P27
P31
P496
0000-0003-4922-7321
P7859
lccn-n2016184033